BRK-B vs CIVB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
CIVB presents a conflicting profile: a weak Piotroski F-Score of 3/9 indicates deteriorating operational health, yet the company maintains a strong track record of earnings beats and an attractive valuation. Trading at a Price-to-Book of 0.91 and well below its Graham Number of $39.0, the stock is fundamentally undervalued from a defensive standpoint. However, the discrepancy between strong revenue growth (15.3%) and flat YoY earnings growth (-1.4%), combined with the low health score, suggests internal inefficiencies. The outlook is neutral as the valuation cushion battles operational weakness.
Compare Another Pair
Related Comparisons
BRK-B vs CIVB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Civista Bancshares, Inc. (CIVB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.